Business Development Director - CDMO

Evergen Remote, Remote, US, Remote
$140,000 - $160,000Remote

About The Position

The Business Development Director will be responsible for driving B2B growth in xenograft biomaterials, with a focus on fresh tissue, fixed tissue, and collagen-based solutions across key clinical segments including Spine, Sports & Orthopedics, Cardiac, and Plastic & Reconstructive surgery. This role requires deep expertise in xenograft processing, applications, and value propositions within a CDMO environment. The ideal candidate will have a proven track record in business development, particularly within the CDMO space, and a passion for deeply understanding their clients’ business and advancing medical technologies. Evergen (formerly RTI Surgical) is a leading CDMO in regenerative medicine, offering a comprehensive portfolio of allograft and xenograft biomaterials at scale.

Requirements

  • Bachelor's degree in Business Administration, Marketing, or a related field; advanced degree preferred.
  • Minimum of 4 years of experience in business development, sales, or a related role within the medical device industry, including at least 2 years within a medical device CDMO environment.
  • Deep understanding of xenograft biomaterials, including fresh tissue, fixed tissue, and collagen (fibrillar, solubilized, or formulated), and their applications in medical devices.
  • Experience working with xenograft sourcing, processing, or manufacturing (e.g., decellularization, sterilization, or collagen processing).
  • Proven track record of achieving sales targets and driving revenue growth.
  • Excellent communication, negotiation, and interpersonal skills.
  • Ability to work collaboratively with cross-functional teams and manage multiple projects simultaneously.
  • Strategic thinker with strong analytical and problem-solving skills.
  • Willingness to travel as needed to meet with clients and attend industry events.

Nice To Haves

  • Experience with xenograft-based product development or commercialization within a CDMO or OEM environment.
  • Familiarity with regulatory and quality considerations specific to xenograft biomaterials.
  • Established network of contacts within the medical device industry.
  • Clinical expertise in focus market segments: Spine, Sports and Orthopedics, Cardiac, or Plastic and Reconstructive Surgery.

Responsibilities

  • Prospect strategic targets with a focus on companies developing products utilizing xenograft biomaterials (fresh tissue, fixed tissue, and collagen), identifying opportunities aligned with our processing and manufacturing capabilities.
  • Develop Key Account Strategies aligned to clients’ xenograft sourcing, processing, and commercialization needs, positioning Evergen as a strategic CDMO partner.
  • Build and maintain strong relationships with existing and potential clients, ensuring a deep understanding of their requirements and internal processes.
  • Orchestrate cross-functional collaboration (R&D, regulatory, and manufacturing) to develop and deliver customized xenograft-based solutions.
  • Translate xenograft platform capabilities (e.g., decellularization, fixation, collagen processing) into customer-specific value propositions.
  • Identify and shape opportunities where xenograft materials can replace or outperform alternative biomaterials, driving differentiation for customers.
  • Lead negotiations and close deals, ensuring favorable terms for the company and high levels of client satisfaction.
  • Monitor market trends and competitor activities to identify opportunities for growth and differentiation.
  • Prepare for and represent the company at industry conferences, trade shows, and other networking events to promote our capabilities and expand our client base.
  • Prepare and present regular reports on business development activities, pipeline status, and sales performance to senior management.
  • Leverage CRM tools to maintain documentation of account planning, prospects, and pipeline development.

Benefits

  • Competitive salary and benefits package.
  • Opportunity to shape and scale a leading xenograft CDMO platform across fresh tissue, fixed tissue, and collagen biomaterials.
  • Collaborative and innovative work environment.
  • Chance to make a significant impact on patient outcomes through advanced biomaterial solutions.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service